STANDARD BIOTLS (LAB)
(Delayed Data from NSDQ)
$2.54 USD
-0.07 (-2.68%)
Updated May 24, 2024 03:59 PM ET
After-Market: $2.54 0.00 (0.00%) 7:58 PM ET
3-Hold of 5 3
D Value F Growth A Momentum F VGM
Detailed Estimates
EPS Estimates
Exp Earnings Date | 8/13/24 |
---|---|
Current Quarter | -0.06 |
EPS Last Quarter | -0.23 |
Last EPS Surprise | -155.56% |
ABR | 1.00 |
Earnings ESP
|
0.00% |
---|---|
Current Year | -0.23 |
Next Year | -0.12 |
EPS (TTM) | -0.60 |
P/E (F1) | NA |
Sales Estimates
Current Qtr (6/2024) |
Next Qtr (9/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Zacks Consensus Estimate | 48.15M | 51.00M | 201.50M | 231.10M |
# of Estimates | 2 | 1 | 2 | 2 |
High Estimate | 48.30M | 51.00M | 203.00M | 235.20M |
Low Estimate | 48.00M | 51.00M | 200.00M | 227.00M |
Year ago Sales | 27.67M | 25.37M | 106.34M | 201.50M |
Year over Year Growth Est. | 74.02% | 101.02% | 89.49% | 14.69% |
Earnings Estimates
Current Qtr (6/2024) |
Next Qtr (9/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Zacks Consensus Estimate | -0.06 | -0.06 | -0.23 | -0.12 |
# of Estimates | 1 | 1 | 1 | 1 |
Most Recent Consensus | NA | NA | NA | NA |
High Estimate | -0.06 | -0.06 | -0.23 | -0.12 |
Low Estimate | -0.06 | -0.06 | -0.23 | -0.12 |
Year ago EPS | -0.14 | -0.15 | -0.41 | -0.23 |
Year over Year Growth Est. | 57.14% | 60.00% | 43.90% | 47.83% |
Agreement - Estimate Revisions
Current Qtr (6/2024) |
Next Qtr (9/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Up Last 7 Days | 0 | 0 | 0 | 0 |
Up Last 30 Days | 1 | 1 | 1 | 1 |
Up Last 60 Days | 0 | 0 | 0 | 0 |
Down Last 7 Days | 0 | 0 | 0 | 0 |
Down Last 30 Days | 0 | 0 | 0 | 0 |
Down Last 60 Days | 0 | 0 | 0 | 0 |
Magnitude - Consensus Estimate Trend
Current Qtr (6/2024) |
Next Qtr (9/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Current | -0.06 | -0.06 | -0.23 | -0.12 |
7 Days Ago | -0.06 | -0.06 | -0.23 | -0.12 |
30 Days Ago | -0.09 | -0.07 | -0.30 | -0.15 |
60 Days Ago | NA | NA | NA | NA |
90 Days Ago | NA | NA | NA | NA |
Upside - Most Accurate Estimate Versus Zacks Consensus
Current Qtr (6/2024) |
Next Qtr (9/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Most Accurate Estimate | -0.06 | -0.06 | -0.23 | -0.12 |
Zacks Consensus Estimate | -0.06 | -0.06 | -0.23 | -0.12 |
Earnings ESP | 0.00% | 0.00% | 0.00% | 0.00% |
Surprise - Reported Earnings History
Quarter Ending (3/2024) |
Quarter Ending (12/2023) |
Quarter Ending (9/2023) |
Quarter Ending (6/2023) |
Average Surprise | |
---|---|---|---|---|---|
Reported | -0.23 | -0.08 | -0.15 | -0.14 | NA |
Estimate | -0.09 | -0.13 | NA | NA | NA |
Difference | -0.14 | 0.05 | NA | NA | -0.05 |
Surprise | -155.56% | 38.46% | NA | NA | -58.55% |
Annual Estimates By Analyst
Zacks Premium Subscription Required Learn more